106 filings
Page 2 of 6
8-K
xlylb8rci ik
19 Oct 23
Tourmaline Bio Announces Closing of Merger with Talaris Therapeutics and Concurrent Private Placement of $75 Million
9:11pm
8-K
ux6k3 zxxp
17 Oct 23
Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio
6:35pm
425
t0156 8pkp9
10 Oct 23
Business combination disclosure
4:32pm
8-K/A
hjll52pw0pny00meskcp
10 Oct 23
Other Events
4:30pm
425
mufwka s7br78e
10 Oct 23
Business combination disclosure
12:00am
8-K
vow6ln3l
6 Oct 23
Talaris Therapeutics Declares Special Dividend
5:30pm
425
jahjd90yfx k222bm
6 Oct 23
Business combination disclosure
5:27pm
8-K
h7qbo5wo27rkzm cf
6 Oct 23
Other Events
5:26pm
425
21w8kt2 xq7t
26 Sep 23
Business combination disclosure
8:24am
8-K
p9ra0k1i oyjv523mhu
26 Sep 23
Regulation FD Disclosure
8:21am
424B3
xsrda
15 Sep 23
Prospectus supplement
6:31am
EFFECT
yevrs7lz r6zw5id
15 Sep 23
Notice of effectiveness
12:15am
SEC STAFF LETTER
jfhvbhjno6l04u
14 Sep 23
SEC staff letter
12:00am
425
sctyg5ws
13 Sep 23
Business combination disclosure
9:14am
8-K
x9ge3s
13 Sep 23
Regulation FD Disclosure
9:13am
CORRESP
992idg7
13 Sep 23
Correspondence with SEC
12:00am
CORRESP
a3m9kpdw0qjm9
11 Sep 23
Correspondence with SEC
12:00am
UPLOAD
pqdybro0qagbf9 ur
6 Sep 23
Letter from SEC
12:00am